RESEARCH
Research
Funding Research for the Cures of Tomorrow
Hope & Heroes bridges the gap between laboratory and clinical research, unlocking new possibilities in the fight against pediatric cancer.
Investment in cutting edge research related to biology, disease origins, and treatment bridges the gap between the laboratory and the clinic, transforming medical discoveries into improved health outcomes for childhood cancer patients everywhere.
Current Hope & Heroes Supported Research:
Developmental Therapeutics Program
Provides the newest drugs for hard to treat diseases as well as access to the newest cancer therapies through enrollment in early-phase clinical trials.
Precision in PediatricsÂ
Research Program
Uses whole-genome analysis to customize treatment for each patient, allowing clinicians to identify the most effective and least invasive options.
Brain and Nervous System Tumor Laboratory
Focuses on understanding the biology of pediatric solid tumors, investigating tumor blood vessel growth, or angiogenesis, as a lens to illuminate the fundamental steps of tumor progression, metastasis, and resistance.
Mullen Foundation
International Initiative for Pediatric Nutrition (IIPAN)
Creates infrastructure and trains clinicians worldwide in order to provide access to the most effective, evidence-based nutritional care for pediatric illnesses in developing countries.
Fegel Foundation Initiative for Drug Delivery Innovation (IDDI)
Endowed chairs
- Rob and Ellen Kapito Professorship of Pediatrics
- Michael Weiner Professorship of Pediatrics
- James A. Wolff Professorship of Pediatrics
- Sid and Helaine Lerner Professorship for Global Integrative Medicine
We fund innovative research studies aimed at detection, prevention, and treatment of pediatric cancers and blood disorders. These vital studies would not be possible without philanthropy. Join us in our efforts to advance groundbreaking research that saves lives.